Contrarily, the study by Pérez‐Pereda et al. showed that serum PACAP‐38 levels were higher in patients with CM compared to patients with EM and HC, with no differences between EM and HC. This evidence concerns the gene ADCYAP1 and cutaneous mastocytosis.